Loading company…
Syros Pharmaceuticals, Inc. is a Cambridge company developing genetic medicines, mainly for cancer.
Founded in 2012 and headquartered in Cambridge, US, Syros Pharmaceuticals, Inc. develops genetic medicines that target the underlying causes of disease, with a focus on oncology. It raised USD 130.00 mn in a PIPE round led by investors including Adage Capital Management and Bain Capital Life Sciences. The company reported revenue of USD 14.88 mn and an EBITDA loss of USD 131.97 mn in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in